4-乙基-7-羟基-3-(4-甲氧基苯基)-二氢-1-苯并吡喃-2-酮 | 5219-17-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 中文名称: 4-乙基-7-羟基-3-(4-甲氧基苯基)-二氢-1-苯并吡喃-2-酮
• 英文名称: 4-ethyl-6-hydroxy-3-(p-methoxyphenyl)-2H-1-benzopyran-2-one
• 英文别名: 4-Ethyl-7-hydroxy-3-<4-methoxy-phenyl>-cumarin；SC 7801；4-ethyl-7-hydroxy-3-(4-methoxy-phenyl)-coumarin；4-Aethyl-7-hydroxy-3-(4-methoxy-phenyl)-cumarin；4-Ethyl-7-hydroxy-3-(p-methoxyphenyl)coumarin；4-ethyl-7-hydroxy-3-(4-methoxyphenyl)chromen-2-one
• CAS: 5219-17-0
• 化学式: C₁₈H₁₆O₄
• 分子量: 296.323
• InChiKey: OFVOGSOIXOYRRC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2932209090

反应信息

• 作为反应物：
  描述：

  4-乙基-7-羟基-3-(4-甲氧基苯基)-二氢-1-苯并吡喃-2-酮 、 硫酸二甲酯 在 sodium hydroxide 作用下， 生成 4-ethyl-7-methoxy-3-(4-methoxy-phenyl)-coumarin
  参考文献：
  名称：

  Mentzer et al., Bulletin de la Societe Chimique de France, 1946, p. 271,274

  摘要：

  DOI：
• 作为产物：
  描述：

  对甲氧基苯乙腈 在 硫酸 、 sodium ethanolate 、 甲苯 作用下， 生成 4-乙基-7-羟基-3-(4-甲氧基苯基)-二氢-1-苯并吡喃-2-酮
  参考文献：
  名称：

  Mentzer et al., Bulletin de la Societe Chimique de France, 1946, p. 271,274

  摘要：

  DOI：

文献信息

• Botanical extract compositions and methods of use
  申请人：The Medical Research and Education Trust

  公开号：EP1808172A2

  公开（公告）日：2007-07-18

  A composition having phytoestrogenic and anti-cancer activity is described. The composition comprises wogonin, isoliquiritigenin, coumestrol, their pharmaceutically acceptable salts or esters, their selectively substituted analogs, or combinations thereof. The compositions may also include an anti-cancer agent and/or an immune stimulant. A method for treating or preventing cancer or an estrogen related disorder includes administering a therapeutically effective amount of the compositions is described. The compositions are particularly useful in the treatment of hormone-related cancers

  描述了一种具有植物雌激素和抗癌活性的组合物。该组合物包括沃戈宁、异水蛭素、库马雌醇、它们的药学上可接受的盐或酯、它们的选择性取代类似物或它们的组合。组合物还可包括抗癌剂和/或免疫促进剂。所述治疗或预防癌症或雌激素相关疾病的方法包括施用治疗有效量的组合物。这些组合物特别适用于治疗与激素相关的癌症
• BOTANICAL EXTRACT COMPOSITIONS WITH ANTI-CANCER OR PHYTOESTROGENIC ACTIVITY COMPRISING WOGONIN, ISOLIQUIRITIGENIN AND/OR COUMESTROL
  申请人：The Medical Research and Education Trust

  公开号：EP1487434A2

  公开（公告）日：2004-12-22
• BOTANICAL EXTRACT COMPOSITIONS WITH ANTI-CANCER ACTIVITY COMPRISING ISOLIQUIRITIGENIN
  申请人：The Medical Research and Education Trust

  公开号：EP1487434B1

  公开（公告）日：2007-05-09
• [EN] BOTANICAL EXTRACT COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSITIONS D'EXTRAIT BOTANIQUE ET PROCEDES D'UTILISATION
  申请人：CHEN SOPHIE PH D

  公开号：WO2003075943A2

  公开（公告）日：2003-09-18

  A composition having phytoestrogenic and anti-cancer activity is described. The composition comprises wogonin, isoliquiritigenin, coumestrol, their pharmaceutically acceptable salts or esters, their selectively substituted analogs, or combinations thereof. The compositions may also include an anti-cancer agent and/or an immune stimulant. A method for treating or preventing cancer or an estrogen related disorder includes administering a therapeutically effective amount of the compositions is described. The compositions are particularly useful in the treatment of hormone-related cancers.
• [EN] BOTANICAL EXTRACT COMPOSITIONS WITH ANTI-CANCER OR PHYTOESTROGENIC ACTIVITY COMPRISING PRENYL FLAVONOIDS<br/>[FR] COMPOSITIONS D'EXTRAITS VEGETAUX AYANT UNE ACTION ANTI-CANCEREUSE OU PHYTOESTROGENIQUE CONTENANT DES FLAVONOIDES DE PRENYLE
  申请人：MEDICAL RES AND EDUCATION TRUS

  公开号：WO2004080474A1

  公开（公告）日：2004-09-23

  A compositon having phytoestrogenic and anti-cancer activity is described. The composition comprises wogonin, isoliquiritigenin, coumestrol, their pharmaceutically acceptable salts or esters, their selectively substituted analogs, or combinations thereof. The compositions may also include an anti-cancer agent and/or an immune stimulant. A method for treating or preventing cancer or an estrogen-related disorder includes administering a therapeutically effective amount of the compositions is described. The compositions are particularly useful in the treatment of hormone-related cancers.